# McKesson Corporation Headquarters – FDA 483, Jul 3, 2018

Source: https://www.keypedia.com/records/483/mckesson-corporation-headquarters/ed4dfcd0-953c-43e1-a97e-e2276fa3e0b6

> FDA 483 for McKesson Corporation Headquarters on July 03, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: McKesson Corporation Headquarters
- Inspection Date: 2018-07-03
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: McKesson Corporation, a wholesale distributor in San Francisco, CA, was cited for deficiencies related to its handling of illegitimate products. The firm's systems were inadequate for identifying, quarantining, and making determinations about suspect or illegitimate products upon receiving notifications. Additionally, procedures for notifying trading partners and retaining sufficient tracing information were found to be deficient.

## Related Officers

- [Investigator](https://www.keypedia.com/people/jolanna-a-norton/5501fea4-4bfd-434c-b2aa-fcf94444f684)
- [Medical Content Writer](https://www.keypedia.com/people/jolanna-a/204c4fa5-c69c-4ed4-8800-267788e163d2)

Company: https://www.keypedia.com/companies/mckesson-corporation-headquarters/0965d62f-b1cd-40c8-959c-7be2fb9456c9

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b